Therapy and Monitoring

The 5-year survival rate for people with cancerous brain or CNS tumors is 34 percent for men and 36 percent for women.7 GE Healthcare’s technology helps to improve visualization and analytical monitoring of disease progression or response to therapy.8
7. https://www.cancer.net/cancer-types/brain-tumor/statistics
8. https://www.gehealthcare.com/en/products/advanced-visualization/all-applications/pet-vcar